The impact of epidermal growth factor re
β
Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh
π
Article
π
2007
π
John Wiley and Sons
π
French
β 403 KB
π 2 views
## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese nonβsmallβcell lung cancer (NSCLC) patients treated with gefitinib. Ninetyβeight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor